Number of Shares
8.79 Mil
Current Holdings Value*
$137.40 Mil
% of Portfolio
6.28%
Total Estimate Gain
$-11.35 Mil
% of Total Estimate Gain
-7.63%

Frazier Life Sciences Management, L.P.'s Arcutis Biotherapeutics Inc Holding Summary

As of 2025-03-31, Frazier Life Sciences Management, L.P. held 8.79 Mil shares of Arcutis Biotherapeutics Inc(ARQT), totaling $137.40 Mil. This investment constitutes 6.28% of their stock portfolio, and Frazier Life Sciences Management, L.P. now holds 7.37% of the outstanding Arcutis Biotherapeutics Inc(ARQT) stock.

The initial trade took place in 2022Q1. And since then Frazier Life Sciences Management, L.P. has made 3 purchases of ARQT, at an average price of $16.92, for a total of 8.79 Mil shares. Based on historical transaction data and ARQT's current price of $15.63, Frazier Life Sciences Management, L.P.'s estimated gain on his ARQT holdings is $-11.35 Mil, reflecting a -7.63% gain to date.

Frazier Life Sciences Management, L.P. ARQT ($15.63) Holding Chart

Frazier Life Sciences Management, L.P. ARQT ($15.63) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1